ChannelAdvisor to Present at the 15th Annual Needham Technology & Media Conference
RESEARCH TRIANGLE PARK, N.C., May 14, 2020 (GLOBE NEWSWIRE) — ChannelAdvisor Corporation (NYSE: ECOM), a leading provider of cloud-based e-commerce […]
STMicroelectronics:
Cartesiam Optimizes NanoEdge™ AI Studiofor STMicroelectronics STM32 Development BoardsNew release of NanoEdge AI Studio brings end-to-end AI experience for developers […]
CoreCivic Releases ESG Report Outlining 5-Year Outcomes of Groundbreaking Reentry Commitments
BRENTWOOD, Tenn., May 14, 2020 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (the Company) released today its annual Environmental, Social […]
Ghislain Houle, CN executive vice-president and chief financial officer, to address the Wolfe Research Transportation & Industrial Conference on May 20
MONTREAL, May 14, 2020 (GLOBE NEWSWIRE) — Ghislain Houle, executive vice-president and chief financial officer of CN (TSX: CNR) (NYSE: […]
Le 20 mai, Ghislain Houle, vice-président exécutif et chef de la direction financière du CN, prendra la parole à la Conférence de Wolfe Research, portant sur le transport et l’industrie
MONTRÉAL, 14 mai 2020 (GLOBE NEWSWIRE) — Ghislain Houle, vice-président exécutif et chef de la direction financière du CN (TSX : CNR) […]
Vaccinex Reports First Quarter 2020 Financial Results and Provides Corporate Update
Approaching key topline data in non-small cell lung cancer and Huntington’s diseaseAdvancing plans to expand pepinemab development to include Alzheimer’s […]
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
PORTLAND, Maine, May 14, 2020 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (the “Company” or “ImmuCell”), a growing animal health company […]
BASi Releases Earnings for Second Quarter of Fiscal 2020
WEST LAFAYETTE, Ind., May 14, 2020 (GLOBE NEWSWIRE) — Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing […]
TRACON Pharmaceuticals Announces Presentation of Positive Clinical Data for Envafolimab in MSI-H/dMMR Cancer at ASCO 2020 Virtual Scientific Program by its Corporate Partners 3D Medicines and Alphamab
Envafolimab Demonstrated a 30% Confirmed Objective Response Rate (ORR) by RECIST by Independent Central Review in Patients with Advanced Refractory […]
Marrone Bio Innovations’ REGALIA® MAXX Receives First Approval for Use on Cannabis and Hemp in Canada
DAVIS, Calif., May 14, 2020 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable […]
